Lonza Group has been a dominant player in the contract development and manufacturing space for decades. We think the outlook for Lonza looks bright, especially as drug manufacturing becomes more ...

Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...

One positive of the last election is that the Trump administration is pro-US manufacturing and is considering tax incentives to reward companies that manufacture in the US and tariffs to punish ...

Baron Small Cap Fund declined in Q4 2024. Who were the top contributors and detractors? Click here to find out.

I-MAB completed a workforce reduction as part of a Realignment Plan aimed at optimizing its operations following the pipeline reprioritization. The company reduced its workforce by approximately 27% ...

Record revenue of €4.57bn in 2024, up +6.1% vs. 2023 Estimated 2024 financial results meet communicated targets: Adjusted EBITDA at c. 35.2%Free cash flow slightly above €340m 2024 revenue at €4,573.7 ...